PHARMACEUTICAL COMPOSITION FOR TREATING ADDICTION IN HUMANS Russian patent published in 2016 - IPC A61K31/4418 A61K31/498 A61P25/30 A61P25/32 A61P25/34 

Abstract RU 2605283 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine and is presented by pharmaceutical composition for treating addiction in humans. Composition contains two active agents: compound with antagonistic activity on 5-HT2 serotonin receptors, selected from cyproheptadine; and compound with antagonistic activity on alpha-1-noradrenergic receptors, selected from prazosin, alfuzosin, terazosin, tamsulosin, silodosin and doxazosin. Invention also relates to combined pharmaceutical product for simultaneous introduction of said agents for treating addiction in humans.

EFFECT: technical result consists in reduction of risk of side effects, simultaneous antagonist activity in relation to alpha-1-noradrenergic receptors and 5-HT2 serotonin receptors, maintaining efficiency, unexpected synergism between agents and stable effect in time.

12 cl, 4 ex, 7 tbl

Similar patents RU2605283C2

Title Year Author Number
MEDICINE CONTAINING SODIUM PENTOZANPOLISULPHATE FOR USE IN THE TREATMENT OF THE OBSTRUCTION OF THE BLADDER AND/OR SYMPTOMS OF THE LOWER URINARY TRACT 2016
  • Swati Vishal Jajodia
RU2680098C1
PHARMACEUTICAL APPLICATION OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUND 2014
  • Lyu Khun
  • Se Sin
  • Sun Khajfen
  • Li Tszin
  • Chzhao Fej
  • Chen In
  • Li Tszen
  • Chzhou Yuj
  • Tszyan Khualyan
  • Chen Kajsyan
RU2704257C2
METHOD FOR DETECTING THE TYPE FOR TREATING PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA 2001
  • Gerter V.V.
  • Kul'Chavenja E.V.
  • Khomjakov V.T.
  • Brizhatjuk E.V.
RU2205001C2
USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE 2018
  • Dolmetsh, Rikardo
  • Gasparini, Fabritsio
  • Dzhons, Donald
  • Gomes-Mankilla, Baltazar
RU2806869C2
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES 2011
  • Germanov Sergej Borisovich
  • Gomzhin Andrej Mikhajlovich
  • Timko Vladimir Grigor'Evich
RU2491070C2
BLOCKING AGENT OF WITHDRAWAL SYNDROME THAT IS A RESULT OF DRUG HABITUATION TO OVER INTAKING DRUGS AND SUBSTANCES CAUSING HABITUATION, PHARMACOLOGICAL COMPOSITION BASED ON THEREOF AND A METHOD OF RELIEF OR PREVENTION OF WITHDRAWAL SYNDROME 1992
  • Anders B'Erk[Se]
  • Ehrik Kristensson[Se]
RU2095062C1
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS 2019
  • Stepanova Eleonora Fedorovna
  • Kuregyan Anna Gurgenovna
  • Spasov Aleksandr Alekseevich
  • Yakovlev Dmitrij Sergeevich
  • Smirnova Lyudmila Andreevna
  • Sultanova Kira Timurovna
  • Agatsarskaya Yana Vladimirovna
  • Kornilov Vladimir Ivanovich
  • Petrov Vladimir Ivanovich
  • Adzhienko Vsevolod Leonidovich
RU2696866C1
THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES 2008
  • Kinkotta Ehntoni Kh.
RU2467743C2
COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ADDICTIONS 2008
  • Chikkochioppo Roberto
RU2492858C2
(-)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, ITS COMPOSITION AND USING AS INHIBITOR OF DOPAMINE REUPTAKE 2002
  • Lippa Arnol'D Stehn
  • Ehpstehjn Dzhozef Uill'Jams
RU2300522C2

RU 2 605 283 C2

Authors

Bernar Filipp

Trovero Fabris

Dates

2016-12-20Published

2012-06-25Filed